
Orforglipron lowered A1C and body weight more than oral semaglutide 25 mg at 52 weeks, but the estimate comes from an indirect comparison.
Access to diabetes self-management education and support services are crucial for improving diabetes outcomes.
Diabetes self-management education and support services (DSMES) can improve a variety of outcomes for patients with type 1 or type 2 diabetes, but not all patients have access to DSMES services equally. A selection of abstracts presented at the American Diabetes Association 84th Scientific Sessions, held June 21 to 24, 2024 in Orlando, Florida, reviewed DSMES services and how access can be improved.
READ MORE:


